You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Sept. 23, 2020 /PRNewswire/ -- Astellas today announced the structure and operating model for its global Patient Centricity organization designed to support the development of innovative health solutions through a deep understanding of the patient experience, medical need and behavioral drivers of care.
Under the leadership of Dr. Anthony Yanni, Senior Vice President and Global Head of Patient Centricity, the organization will be comprised of four distinct teams – Medical Intelligence and Patient Insights, Patient Insights and Solutions, the Behavioral Science Consortium and Patient Partnerships – working together to apply unique insights from patients, caregivers, healthcare providers and advocacy partners in considering how to prioritize Astellas resources to the projects with the potential to have the biggest impact on patients' lives:
"Drug development has historically focused exclusively on scientific possibility rather than integrating real-world patient insights – especially in the research space. At Astellas, we've established processes that balance 'Can We?' with 'Should We?'," said Yanni. "To be most-effective, however, integration of the patient perspective must start early in the research and discovery process and be incorporated throughout the continuum through to development and utilization. This comprehensive approach to patient-focused medicines development is what makes Astellas Patient Centricity unique, and I am thrilled with the talent we have attracted and the momentum we have established to make this vision a reality."
As part of the new structure, Yanni announced a leadership team based in the U.S. and the company's global headquarters in Japan, comprised of industry veterans with a deep commitment to innovating based on an intimate understanding of real-world patient needs:
"With these leaders, and the many colleagues around the world who have joined Patient Centricity over the past few months, we have now in place a best-in-class team dedicated to ensuring Astellas brings a conscious awareness of the patient to everything we do," said Yanni.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.com/us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma-us/.
SOURCE Astellas Pharma Inc.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.